Many people with asthma, ABPA (Allergic Bronchopulmonary Aspergillosis), or other eosinophilic lung conditions describe sudden “crashes” where they feel feverish, inflamed, and completely drained — even when tests don’t show an infection. This can be confusing and worrying, but there is a clear explanation.
🔬 The role of eosinophils
-
Eosinophils are a type of white blood cell that drive allergic and inflammatory reactions.
-
When too many become activated, they release chemicals and proteins that cause:
-
Inflammation in the airways and body
-
Fatigue and muscle aches
-
“Flu-like” symptoms
-
-
In eosinophilic diseases such as ABPA, severe asthma, or EGPA, these episodes are often described as flare-ups.
🧩 Common triggers of flares
-
Stress – both emotional and physical stress can tip the immune system into overdrive.
-
Biologic not yet started – until a biologic (e.g. mepolizumab, benralizumab, tezepelumab) calms eosinophil activity, your immune system may stay “over-reactive.”
-
Mechanical strain – back pain, muscle strain, or other physical problems can amplify inflammation.
-
Minor viral infections – even a tiny cold virus, too mild to register on tests, can trigger eosinophil-driven inflammation.
📉 Why symptoms come and go
-
Many patients feel very unwell at home (fever, aches, exhaustion), but by the time they see a doctor, their vital signs look normal again.
-
This doesn’t mean the flare wasn’t real. Eosinophil flares often burn out quickly, leaving behind fatigue and soreness that can last for days.
⚠️ When to seek medical advice
Contact your healthcare team if you notice:
-
Persistent or high fever
-
Worsening shortness of breath
-
New or increased cough
-
Chest pain
These may signal an infection or another complication that needs treatment.
✅ Key message
Yes — high eosinophils can cause flare-ups that feel like sudden illness without infection. Many patients describe exactly this: sudden feverishness, inflammation, aches, and feeling “knocked flat” for a few days.
Biologic medicines are designed to reduce eosinophil activity, helping to cut down the number and severity of these flares.
Share this post
Latest News posts
How the UK evaluates new drugs for use in the NHS
March 4, 2025
ABPA & CPA: Patient priorities
February 25, 2025
I Have ABPA and feel worse if I sleep with windows open
February 25, 2025
How the NHS funds medications
February 25, 2025
Thinking about joining a clinical trial? What are your concerns?
December 12, 2024
Biologics & ABPA – what are they and what can they do?
October 19, 2024
UK National RSV vaccination program launched
July 26, 2024
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
